All data are based on the daily closing price as of April 3, 2026
j

Johnson Chemical Pharmaceutical Works

4747.TWO
1.71 USD
-0.04
-2.29%

Overview

Last close
1.71 usd
Market cap
76.70M usd
52 week high
2.65 usd
52 week low
1.69 usd
Target price
N/A usd

Valuation

P/E
45.8824
Forward P/E
N/A
Price/Sales
4.3058
Price/Book Value
1.4693
Enterprise Value
50.75M usd
EV/Revenue
2.8447
EV/EBITDA
18.5322

Key financials

Revenue TTM
17.84M usd
Gross Profit TTM
7.15M usd
EBITDA TTM
2.93M usd
Earnings per Share
0.04 usd
Dividend
N/A usd
Total assets
66.71M usd
Net debt
N/A usd

About

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is based in New Taipei City, Taiwan.
  • Symbol
    4747.TWO
  • Exchange
    TWO
  • Isin
    TW0004747001
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. P. H. Huang
  • Headquarter
    New Taipei City
  • Web site
    https://www.jcpjohnson.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top